Anzeige
Mehr »
Login
Dienstag, 21.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News! 22 Jahre "BlueChip"-Power nun bei NurExone!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JWL4 | ISIN: NO0010598683 | Ticker-Symbol: HBQ
Frankfurt
20.05.24
09:18 Uhr
0,160 Euro
0,000
0,00 %
1-Jahres-Chart
HOFSETH BIOCARE ASA Chart 1 Jahr
5-Tage-Chart
HOFSETH BIOCARE ASA 5-Tage-Chart
RealtimeGeldBriefZeit
0,1600,22020.05.

Aktuelle News zur HOFSETH BIOCARE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoHofseth Biocare ASA: First Quarter 2024 Financial Report62The first quarter of 2024 continued on the positive trend for HBC. Sales revenues came in at NOK 52m vs NOK 44m last year, a growth of 17 % YoY. The underlying growth we are seeing is coming from both...
► Artikel lesen
10.05.Hofseth Biocare ASA: Annual General Meeting completed2
19.04.Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 20242
19.04.Hofseth Biocare ASA: HBC ANNUAL REPORT 20232
08.04.Hofseth BioCare ASA: NOTIFICATION OF MAJOR HOLDINGS4
05.04.Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING5
21.03.Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION-
14.03.Hofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWN3
09.02.Hofseth Biocare ASA: Fourth Quarter 2023 And Full Year Financial Report239HBC had gross operating revenues of NOK 47.4m (33.6m) in the fourth quarter and NOK 218.5m (120.4m) for the full year. Adjusted for the sale of assets in the second quarter, operating revenues were...
► Artikel lesen
06.02.Hofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal therapy demonstrating significant anti-tumour activity1
09.01.Hofseth Biocare ASA: SHARE CAPITAL INCREASE REGISTERED1
04.01.Hofseth Biocare ASA: EXTRAORDINARY GENERAL MEETING CONCLUDED4
20.12.23Hofseth International agrees to USD 13.8 million debt-for-equity swap with Hofseth BioCare2
15.12.23Hofseth Biocare ASA: EGM Notice Correction-
14.12.23Hofseth Biocare ASA: Notice of an extraordinary general meeting2
13.12.23Hofseth Biocare ASA: SIGNIFICANT NEW INVESTMENT OF NOK 144 MILLION FROM HOFSETH INTERNATIONAL INTO HBC3
27.11.23Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING4
27.11.23Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE2
10.11.23Hofseth Biocare ASA: Hofseth Biocare Asa: Third Quarter 2023 Financial Report249The third quarter of 2023 shows a significant growth of forty percent in sales compared to the same period last year and the increase in margins in Q2 continues. Sales revenues ended at NOK 49.9m...
► Artikel lesen
25.08.23Hofseth Biocare ASA: Second Quarter 2023 Financial Report342The second quarter of 2023 shows a 100 % growth in sales compared to the same period last year and strong increase in margins. Sales revenues ended at NOK 52.9m vs NOK 25.8m last year. The underlying...
► Artikel lesen
Seite:  Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1